Literature DB >> 19948779

Sensitivity analyses to estimate the potential impact of unmeasured confounding in causal research.

Rolf H H Groenwold1, David B Nelson, Kristin L Nichol, Arno W Hoes, Eelko Hak.   

Abstract

BACKGROUND: The impact of unmeasured confounders on causal associations can be studied by means of sensitivity analyses. Although several sensitivity analyses are available, these are used infrequently. This article is intended as a tutorial on sensitivity analyses, in which we discuss three methods to conduct sensitivity analysis.
METHODS: Each method is based on assumed associations between confounder and exposure, confounder and outcome and the prevalence of the confounder in the population at large. In the first method an unmeasured confounder is simulated and subsequently adjusted. The other two methods are analytical methods, in which either the (adjusted) effect estimate is multiplied with a factor based on assumed confounder characteristics, or the (adjusted) risks for the outcome among exposed and unexposed subjects are adjusted by such a factor. These methods are illustrated with a clinical example on influenza vaccine effectiveness.
RESULTS: When applied to a dataset constructed to assess the effect of influenza vaccination on mortality, the three reviewed methods provided similar results. After adjustment for observed confounders, influenza vaccination reduced mortality by 42% [odds ratio (OR) 0.58, 95% confidence interval (CI) 0.46-0.73]. To arrive at a 95% CI including one requires a very common confounder (40% prevalence) with strong associations with both vaccination status and mortality, respectively OR < or =0.3 and OR > or =3.0 (OR 0.79, 95% CI 0.62-1.00).
CONCLUSIONS: In every non-randomized study on causal associations the robustness of the results with respect to unmeasured confounding can, and should, be assessed using sensitivity analyses.

Mesh:

Substances:

Year:  2009        PMID: 19948779     DOI: 10.1093/ije/dyp332

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  34 in total

1.  Using claims data to predict dependency in activities of daily living as a proxy for frailty.

Authors:  Keturah R Faurot; Michele Jonsson Funk; Virginia Pate; M Alan Brookhart; Amanda Patrick; Laura C Hanson; Wendy Camelo Castillo; Til Stürmer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-10-21       Impact factor: 2.890

2.  Effectiveness of Potential Interventions to Change Gendered Social Norms on Prevalence of Intimate Partner Violence in Uganda: a Causal Inference Approach.

Authors:  Damazo T Kadengye; Samuel Iddi; Lauren Hunter; Sandra I McCoy
Journal:  Prev Sci       Date:  2019-10

3.  When the entire population is the sample: strengths and limitations in register-based epidemiology.

Authors:  Lau Caspar Thygesen; Annette Kjær Ersbøll
Journal:  Eur J Epidemiol       Date:  2014-01-10       Impact factor: 8.082

Review 4.  Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.

Authors:  Md Jamal Uddin; Rolf H H Groenwold; Mohammed Sanni Ali; Anthonius de Boer; Kit C B Roes; Muhammad A B Chowdhury; Olaf H Klungel
Journal:  Int J Clin Pharm       Date:  2016-04-18

5.  Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data.

Authors:  Andreas D Meid; Anna von Medem; Dirk Heider; Jürgen-Bernhard Adler; Christian Günster; Hanna M Seidling; Renate Quinzler; Hans-Helmut König; Walter E Haefeli
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

Review 6.  Timing to perform VATS for traumatic-retained hemothorax (a systematic review and meta-analysis).

Authors:  Behrad Ziapour; Elmira Mostafidi; Homayoun Sadeghi-Bazargani; Ali Kabir; Ikenna Okereke
Journal:  Eur J Trauma Emerg Surg       Date:  2019-12-17       Impact factor: 3.693

7.  Association between Palliative Care and End-of-Life Resource Use for Older Adults Hospitalized with Septic Shock.

Authors:  Jason H Maley; Christopher M Worsham; Bruce E Landon; Jennifer P Stevens
Journal:  Ann Am Thorac Soc       Date:  2020-08

8.  Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma.

Authors:  James D Nordin; Gabriela Vazquez-Benitez; Avalow Olsen; Leslie C Kuckler; Ashley Y Gao; Elyse O Kharbanda
Journal:  Vaccine       Date:  2019-06-10       Impact factor: 3.641

9.  Acute and recent air pollution exposure and cardiovascular events at labour and delivery.

Authors:  Tuija Männistö; Pauline Mendola; Katherine Laughon Grantz; Kira Leishear; Rajeshwari Sundaram; Seth Sherman; Qi Ying; Danping Liu
Journal:  Heart       Date:  2015-06-23       Impact factor: 5.994

10.  Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.

Authors:  Jill M Ferdinands; Manjusha Gaglani; Shekhar Ghamande; Emily T Martin; Donald Middleton; Arnold S Monto; Fernanda Silveira; Helen K Talbot; Richard Zimmerman; Emily R Smith; Manish Patel
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.